Search research articles
Contact Us
Filters
Showing results (41-50 of 107) with videos related to
Page
of 11
Sort By:
Crohn'S & Colitis 360
|
July 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohort
Mohmmed Tauseef Sharip, Dharmaraj Durai, Eva Vayreda, et al.
Nature Communications
|
November 6, 2024
Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci
Elizabeth C Goode, Laura Fachal, Nikolaos Panousis, et al.
Journal of Crohn'S & Colitis
|
September 7, 2024
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
Eman Al Sulais, Edouard Louis, Bernd Bokemeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential
Deena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Journal of Crohn'S & Colitis
|
June 23, 2021
ECCO Topical Review: Refractory Inflammatory Bowel Disease
Tim Raine, Bram Verstockt, Uri Kopylov, et al.
Pragmatic and Observational Research
|
March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis
Andrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Rheumatology (Oxford, England)
|
February 23, 2024
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings
Sarah Sayers, Danielle Lam, Qutab Shah, et al.
BMJ Open
|
February 18, 2019
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial
Martin Geoffrey Thomas, Carrie Bayliss, Simon Bond, et al.
Frontline Gastroenterology
|
June 27, 2020
Practice pattern variability in the management of acute severe colitis: a UK provider survey
Shaji Sebastian, Jessica Lisle, Sreedhar Subramanian, et al.
Journal of Crohn'S & Colitis
|
April 14, 2026
Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization
Tim Raine, James D Lewis, Gareth C Parkes, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 107) with videos related to
Sort By:
Page
of 11
Crohn'S & Colitis 360
|
July 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohort
Mohmmed Tauseef Sharip, Dharmaraj Durai, Eva Vayreda, et al.
Nature Communications
|
November 6, 2024
Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci
Elizabeth C Goode, Laura Fachal, Nikolaos Panousis, et al.
Journal of Crohn'S & Colitis
|
September 7, 2024
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
Eman Al Sulais, Edouard Louis, Bernd Bokemeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential
Deena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Journal of Crohn'S & Colitis
|
June 23, 2021
ECCO Topical Review: Refractory Inflammatory Bowel Disease
Tim Raine, Bram Verstockt, Uri Kopylov, et al.
Pragmatic and Observational Research
|
March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis
Andrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Rheumatology (Oxford, England)
|
February 23, 2024
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings
Sarah Sayers, Danielle Lam, Qutab Shah, et al.
BMJ Open
|
February 18, 2019
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial
Martin Geoffrey Thomas, Carrie Bayliss, Simon Bond, et al.
Frontline Gastroenterology
|
June 27, 2020
Practice pattern variability in the management of acute severe colitis: a UK provider survey
Shaji Sebastian, Jessica Lisle, Sreedhar Subramanian, et al.
Journal of Crohn'S & Colitis
|
April 14, 2026
Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization
Tim Raine, James D Lewis, Gareth C Parkes, et al.
Page
of 11